platinum has been researched along with pf-06463922 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baglivo, S; Bellezza, G; Bonaiti, A; Colafigli, C; Di Girolamo, B; Ludovini, V; Mandarano, M; Matocci, R; Metelli, N; Metro, G; Roila, F | 1 |
1 other study(ies) available for platinum and pf-06463922
| Article | Year |
|---|---|
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Humans; Lactams, Macrocyclic; Lung Neoplasms; Pemetrexed; Platinum; Protein Kinase Inhibitors | 2023 |